{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:42:45Z","timestamp":1778622165800,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/71\/2022-NCD-III"],"award-info":[{"award-number":["3\/2\/2\/71\/2022-NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82460-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T23:19:18Z","timestamp":1751411958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression of ALDH1 isotypes and its potential as a prognostic and diagnostic marker in patients with muscle invasive bladder cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Sumit","family":"Dey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Pattanaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandita","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monidipa","family":"Konar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ipsita","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arup Kumar","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravimohan Suryanarayan","family":"Mavuduru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"82460_CR1","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/cam4.4625","volume":"11","author":"W Shangguan","year":"2022","unstructured":"Shangguan, W. et al. Conditional survival of trimodal therapy for nonmetastatic muscle-invasive bladder cancer: A SEER database analysis. Cancer Med. 11, 2356\u20132365. https:\/\/doi.org\/10.1002\/cam4.4625 (2022).","journal-title":"Cancer Med."},{"key":"82460_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.euf.2020.01.007","volume":"6","author":"G Gakis","year":"2020","unstructured":"Gakis, G. Management of muscle-invasive bladder cancer in the 2020s: Challenges and perspectives. Eur. Urol. Focus 6, 632\u2013638. https:\/\/doi.org\/10.1016\/j.euf.2020.01.007 (2020).","journal-title":"Eur. Urol. Focus"},{"key":"82460_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/cancers15041323","volume":"15","author":"HW Lee","year":"2023","unstructured":"Lee, H. W., Kwon, W.-A., Nguyen, L. N. T., Phan, D. T. T. & Seo, H. K. Approaches to clinical complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer: Possibilities and limitations. Cancers 15, 1323 (2023).","journal-title":"Cancers"},{"key":"82460_CR4","doi-asserted-by":"publisher","unstructured":"Aragon-Ching, J. B., Werntz, R. P., Zietman, A. L. & Steinberg, G. D. Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 38, 307\u2013318. https:\/\/doi.org\/10.1200\/edbk_201227 (2018).","DOI":"10.1200\/edbk_201227"},{"key":"82460_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1186\/s12885-021-08840-2","volume":"21","author":"FJ Hinsenveld","year":"2021","unstructured":"Hinsenveld, F. J. et al. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: The PRE-PREVENCYS trial. BMC Cancer 21, 1161. https:\/\/doi.org\/10.1186\/s12885-021-08840-2 (2021).","journal-title":"BMC Cancer"},{"key":"82460_CR6","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder Cancer: A Review. JAMA 324, 1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598 (2020).","journal-title":"JAMA"},{"key":"82460_CR7","doi-asserted-by":"publisher","first-page":"9653244","DOI":"10.1155\/2022\/9653244","volume":"2022","author":"S Bisht","year":"2022","unstructured":"Bisht, S. et al. Cancer stem cells: From an insight into the basics to recent advances and therapeutic targeting. Stem Cells International 2022, 9653244. https:\/\/doi.org\/10.1155\/2022\/9653244 (2022).","journal-title":"Stem Cells International"},{"key":"82460_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-022-02904-1","volume":"13","author":"F Ju","year":"2022","unstructured":"Ju, F. et al. Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Research & Therapy 13, 233. https:\/\/doi.org\/10.1186\/s13287-022-02904-1 (2022).","journal-title":"Stem Cell Research & Therapy"},{"key":"82460_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110120","volume":"87","author":"M Poturnajova","year":"2021","unstructured":"Poturnajova, M., Kozovska, Z. & Matuskova, M. Aldehyde dehydrogenase 1A1 and 1A3 isoforms\u2014mechanism of activation and regulation in cancer. Cellular Signalling 87, 110120. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110120 (2021).","journal-title":"Cellular Signalling"},{"key":"82460_CR10","doi-asserted-by":"publisher","first-page":"3904645","DOI":"10.1155\/2019\/3904645","volume":"2019","author":"G Vassalli","year":"2019","unstructured":"Vassalli, G. Aldehyde dehydrogenases: Not just markers, but functional regulators of stem cells. Stem Cells International 2019, 3904645. https:\/\/doi.org\/10.1155\/2019\/3904645 (2019).","journal-title":"Stem Cells International"},{"key":"82460_CR11","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1002\/mco2.195","volume":"4","author":"J Xia","year":"2023","unstructured":"Xia, J., Li, S., Liu, S. & Zhang, L. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets. MedComm 4, e195. https:\/\/doi.org\/10.1002\/mco2.195 (2023).","journal-title":"MedComm"},{"key":"82460_CR12","doi-asserted-by":"publisher","first-page":"950241","DOI":"10.3389\/fcell.2022.950241","volume":"10","author":"J Tan","year":"2022","unstructured":"Tan, J. et al. The origin and evolution of bladder cancer stem cells. Frontiers in Cell and Developmental Biology 10, 950241. https:\/\/doi.org\/10.3389\/fcell.2022.950241 (2022).","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"82460_CR13","doi-asserted-by":"publisher","unstructured":"Liu, C. J. et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Briefings in Bioinformatics 24, https:\/\/doi.org\/10.1093\/bib\/bbac558 (2023).","DOI":"10.1093\/bib\/bbac558"},{"key":"82460_CR14","doi-asserted-by":"publisher","first-page":"795762","DOI":"10.3389\/fmed.2022.795762","volume":"9","author":"M Zanoni","year":"2022","unstructured":"Zanoni, M., Bravaccini, S., Fabbri, F. & Arienti, C. Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance. Frontiers in Medicine 9, 795762. https:\/\/doi.org\/10.3389\/fmed.2022.795762 (2022).","journal-title":"Frontiers in Medicine"},{"key":"82460_CR15","doi-asserted-by":"publisher","unstructured":"Ojha, R., Jha, V., Singh, S. K. & Bhattacharyya, S. Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842, 2073\u20132086. https:\/\/doi.org\/10.1016\/j.bbadis.2014.07.007 (2014).","DOI":"10.1016\/j.bbadis.2014.07.007"},{"key":"82460_CR16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/jjco\/hyw111","volume":"46","author":"K Wakai","year":"2016","unstructured":"Wakai, K. et al. Clinical predictors for high-grade bladder cancer before first-time transurethral resection of the bladder tumor: A retrospective cohort study. Japanese Journal of Clinical Oncology 46, 964\u2013967. https:\/\/doi.org\/10.1093\/jjco\/hyw111 (2016).","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"82460_CR17","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/(sici)1097-0142(19990615)85:12<2638::aid-cncr21>3.0.co;2-v","volume":"85","author":"L Cheng","year":"1999","unstructured":"Cheng, L. et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: A critical evaluation of the depth of muscle invasion. Cancer 85, 2638\u20132647. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990615)85:12%3c2638::aid-cncr21%3e3.0.co;2-v (1999).","journal-title":"Cancer"},{"key":"82460_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/BLC-200273","volume":"6","author":"J Loloi","year":"2020","unstructured":"Loloi, J. et al. In the world of bladder tumors: Size does matter. Bladder Cancer (Amsterdam, Netherlands) 6, 195\u2013200. https:\/\/doi.org\/10.3233\/BLC-200273 (2020).","journal-title":"Bladder Cancer (Amsterdam, Netherlands)"},{"key":"82460_CR19","doi-asserted-by":"publisher","unstructured":"Bartsch, G. C. et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. European urology 51, 690\u2013697; discussion 697\u2013698, https:\/\/doi.org\/10.1016\/j.eururo.2006.07.009 (2007).","DOI":"10.1016\/j.eururo.2006.07.009"},{"key":"82460_CR20","doi-asserted-by":"publisher","unstructured":"Oh, J. J. et al. Association Between preoperative hydronephrosis and prognosis after radical cystectomy among patients with bladder cancer: A systemic review and meta-analysis. Frontiers in Oncology 9, https:\/\/doi.org\/10.3389\/fonc.2019.00158 (2019).","DOI":"10.3389\/fonc.2019.00158"},{"key":"82460_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1158\/1055-9965.Epi-09-0865","volume":"19","author":"Y Su","year":"2010","unstructured":"Su, Y. et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiology, Biomarkers & Prevention\u202f: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 19, 327\u2013337. https:\/\/doi.org\/10.1158\/1055-9965.Epi-09-0865 (2010).","journal-title":"Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"key":"82460_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.canep.2015.03.003","volume":"39","author":"N Xu","year":"2015","unstructured":"Xu, N. et al. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer. Cancer Epidemiology 39, 375\u2013381. https:\/\/doi.org\/10.1016\/j.canep.2015.03.003 (2015).","journal-title":"Cancer Epidemiology"},{"key":"82460_CR23","doi-asserted-by":"publisher","first-page":"13684","DOI":"10.1038\/s41598-021-93245-1","volume":"11","author":"M Blomqvist","year":"2021","unstructured":"Blomqvist, M. et al. Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer. Scientific Reports 11, 13684. https:\/\/doi.org\/10.1038\/s41598-021-93245-1 (2021).","journal-title":"Scientific Reports"},{"key":"82460_CR24","doi-asserted-by":"publisher","unstructured":"Gelardi, E. L. M. et al. A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro. Cancers 13, https:\/\/doi.org\/10.3390\/cancers13020356 (2021).","DOI":"10.3390\/cancers13020356"},{"key":"82460_CR25","doi-asserted-by":"publisher","unstructured":"Nwani, N. G. et al. A novel ALDH1A1 inhibitor targets cells with stem cell characteristics in ovarian cancer. Cancers 11, https:\/\/doi.org\/10.3390\/cancers11040502 (2019).","DOI":"10.3390\/cancers11040502"},{"key":"82460_CR26","doi-asserted-by":"publisher","unstructured":"Zhang, Z. et al. Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression. iScience 26, 108142. https:\/\/doi.org\/10.1016\/j.isci.2023.108142 (2023).","DOI":"10.1016\/j.isci.2023.108142"},{"key":"82460_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.yexcr.2017.11.004","volume":"362","author":"NN Wang","year":"2018","unstructured":"Wang, N. N. et al. Targeting ALDH2 with disulfiram\/copper reverses the resistance of cancer cells to microtubule inhibitors. Experimental Cell Research 362, 72\u201382. https:\/\/doi.org\/10.1016\/j.yexcr.2017.11.004 (2018).","journal-title":"Experimental Cell Research"},{"key":"82460_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka, V. et al. Aldehyde dehydrogenase inhibitors: a Comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacological Reviews 64, 520\u2013539. https:\/\/doi.org\/10.1124\/pr.111.005538 (2012).","journal-title":"Pharmacological Reviews"},{"key":"82460_CR29","doi-asserted-by":"publisher","first-page":"762820","DOI":"10.3389\/fonc.2022.762820","volume":"12","author":"MW Caminear","year":"2022","unstructured":"Caminear, M. W., Harrington, B. S., Kamdar, R. D., Kruhlak, M. J. & Annunziata, C. M. Disulfiram transcends ALDH inhibitory activity when targeting ovarian cancer tumor-initiating cells. Frontiers in Oncology 12, 762820. https:\/\/doi.org\/10.3389\/fonc.2022.762820 (2022).","journal-title":"Frontiers in Oncology"},{"key":"82460_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.18632\/oncotarget.604","volume":"3","author":"J Triscott","year":"2012","unstructured":"Triscott, J. et al. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide. Oncotarget 3, 1112\u20131123. https:\/\/doi.org\/10.18632\/oncotarget.604 (2012).","journal-title":"Oncotarget"},{"key":"82460_CR31","doi-asserted-by":"publisher","unstructured":"Idrisova, K. F., Simon, H. U. & Gomzikova, M. O. Role of Patient-Derived Models of Cancer in Translational Oncology. Cancers 15, https:\/\/doi.org\/10.3390\/cancers15010139 (2022).","DOI":"10.3390\/cancers15010139"},{"key":"82460_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bju.13760","volume":"119","author":"SL Woldu","year":"2017","unstructured":"Woldu, S. L., Bagrodia, A. & Lotan, Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU international 119, 371\u2013380. https:\/\/doi.org\/10.1111\/bju.13760 (2017).","journal-title":"BJU international"},{"key":"82460_CR33","unstructured":"Eble, J. N., Tavassoli, F. A. & Devilee, P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs (Iarc, 2003)."},{"key":"82460_CR34","doi-asserted-by":"crossref","unstructured":"Sobin, L. H., Gospodarowicz, M. K. & Wittekind, C. TNM Classification of Malignant Tumours (John Wiley & Sons, 2011).","DOI":"10.1002\/9780471420194.tnmc26"},{"key":"82460_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse, P. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 92, 205\u2013216. https:\/\/doi.org\/10.1093\/jnci\/92.3.205 (2000).","journal-title":"Journal of the National Cancer Institute"},{"key":"82460_CR36","doi-asserted-by":"publisher","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European journal of cancer (Oxford, England : 1990) 45, 228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026 (2009).","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"82460_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","volume":"198","author":"SS Chang","year":"2017","unstructured":"Chang, S. S. et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline. The Journal of Urology 198, 552\u2013559. https:\/\/doi.org\/10.1016\/j.juro.2017.04.086 (2017).","journal-title":"The Journal of Urology"},{"key":"82460_CR38","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese, F., Bukhari, A. B., Malhotra, R. & De, A. IHC profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLOS ONE 9, e96801. https:\/\/doi.org\/10.1371\/journal.pone.0096801 (2014).","journal-title":"PLOS ONE"},{"key":"82460_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/jomfp.JOMFP_234_16","volume":"21","author":"DR Mane","year":"2017","unstructured":"Mane, D. R., Kale, A. D. & Belaldavar, C. Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: An immunohistochemical quantitative analysis. Journal of Oral and Maxillofacial Pathology: JOMFP 21, 211\u2013217. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_234_16 (2017).","journal-title":"Journal of Oral and Maxillofacial Pathology: JOMFP"},{"key":"82460_CR40","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.1803595116","volume":"116","author":"J Mullenders","year":"2019","unstructured":"Mullenders, J. et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proceedings of the National Academy of Sciences of the United States of America 116, 4567\u20134574. https:\/\/doi.org\/10.1073\/pnas.1803595116 (2019).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"82460_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/bcr1275","volume":"7","author":"G Dimri","year":"2005","unstructured":"Dimri, G., Band, H. & Band, V. Mammary epithelial cell transformation: Insights from cell culture and mouse models. Breast Cancer Research 7, 171. https:\/\/doi.org\/10.1186\/bcr1275 (2005).","journal-title":"Breast Cancer Research"},{"key":"82460_CR42","doi-asserted-by":"publisher","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","DOI":"10.1006\/meth.2001.1262"},{"key":"82460_CR43","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research 45, W98-w102. https:\/\/doi.org\/10.1093\/nar\/gkx247 (2017).","journal-title":"Nucleic Acids Research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82460-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T23:19:19Z","timestamp":1751411959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["82460"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82460-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22599"}}